Stem Cell Therapy For Type 1 Diabetes Mellitus

Listing a study does not mean it has been evaluated by the u s.

Stem cell therapy for type 1 diabetes mellitus.

Mesenchymal stem cell therapy for type 1 diabetes mellitus patients the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Type 1 diabetes mellitus t1dm is the most common chronic autoimmune disease in young patients and is characterized by the loss of pancreatic β cells. Any potential stem cell based cure for t1dm should address the need for beta cell replacement as well as control of the autoimmune response to cells which express insulin. Pancreas and islet transplantation have emerged as.

As a result the body becomes insulin deficient and hyperglycemic. Insulin secreting adipose derived mesenchymal stromal cells with bone marrow derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. The use of stem cells in regenerative medicine holds great promise for the cure of many diseases including type 1 diabetes mellitus t1dm. The primary function of stem cell therapy for diabetes is to repair and regenerate damaged tissue involving nerves blood vessels and even the kidneys and pancreas.

Administration or injection of exogenous insulin cannot mimic the endogenous insulin secreted by a healthy pancreas. Cytotherapy 17 7 940 947.